Aberrant Transforming Growth Factor β1 Signaling and SMAD4 Nuclear Translocation Confer Epigenetic Repression of ADAM19 in Ovarian Cancer

Transforming growth factor-beta (TGF-β)/SMAD signaling is a key growth regulatory pathway often dysregulated in ovarian cancer and other malignancies. Although loss of TGF-β-mediated growth inhibition has been shown to contribute to aberrant cell behavior, the epigenetic consequence(s) of impaired T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chan, Michael WY, Huang, Yi-Wen, Hartman-Frey, Corinna, Kuo, Chieh-Ti, Deatherage, Daniel, Qin, Huaxia, Cheng, Alfred SL, Yan, Pearlly S, Davuluri, Ramana V, Huang, Tim H-M, Nephew, Kenneth P, Lin, Huey-Jen L
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press Inc. 2008
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2517635/
https://ncbi.nlm.nih.gov/pubmed/18714391
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados